SAN FRANCISCO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- #" Featured Image for Upblocks LLC Featured Image for Upblocks LLC
Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21